DSS, Inc. Reports $6.35 Million Net Loss in Q1 2026, Revenue Declines 13%

DSS, Inc. reported a net loss of $6.35 million for the first quarter of 2026, a 20% increase from the $5.30 million loss recorded in the same period of 2025. Total revenue for the quarter decreased by 13% to $4.33 million, down from $4.95 million year-over-year. The decline in revenue was primarily attributed to significant drops in the company's securities and commercial lending segments, which saw decreases of 83% and 71%, respectively. The biotechnology segment also experienced a 53% decline in revenue, while the printed products segment managed a modest increase of 4%.

The company's cost of revenue rose to $5.53 million, a 7% increase compared to $5.19 million in the prior year. This increase was driven by higher costs associated with printed products, which rose by 17% due to increased production costs. In contrast, costs in the securities segment decreased by 22% as a result of reduced operational expenses following the sale of certain facilities. Overall, total costs and expenses for the quarter amounted to $9.82 million, up from $8.68 million in the previous year.

DSS, Inc. has been actively pursuing strategic developments, including a recent acquisition of a convertible bond investment from True Partners Capital Holding Limited, valued at approximately $8.52 million. This investment is expected to enhance the company's financial position and provide additional capital for future growth. The company also reported an increase in stock-based compensation expenses, which rose by 65% to $1.44 million, reflecting the issuance of shares to various stakeholders as part of its compensation strategy.

Operationally, DSS, Inc. has seen fluctuations in its customer base and engagement metrics. The company reported a decrease in accounts receivable, which fell to $2.04 million from $2.25 million, indicating improved collection efforts. However, the overall cash position weakened, with cash and cash equivalents decreasing to $4.94 million from $6.21 million at the end of 2025. The company continues to face challenges in its commercial lending segment, with several loans going into non-accrual status, impacting revenue generation.

Looking ahead, DSS, Inc. remains focused on enhancing its operational efficiency and exploring new market opportunities. The company is committed to reducing expenses and cash burn across all business lines while seeking to stabilize its financial performance. Management believes that with its current cash reserves and potential access to additional capital, it can meet its operational needs for at least the next 12 months. The company is also evaluating its strategic direction, particularly in the commercial lending sector, to better align with market demands and improve profitability.